UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 _____________________________ FORM 20-F _____________________________ ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) or (g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended March 31, 2019 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☐ SHELL COMPANY REPORT PURSUANT TO SECTION 13 ...

Start Time: 13:00 January 1, 0000 1:50 PM ET Acasti Pharma, Inc. (NASDAQ:ACST) Q3 2019 Earnings Conference Call February 14, 2019, 13:00 PM ET Company Participants Jan D’Alvise - President and CEO Pierre Lemieux - COO and Chief Scientific Officer Brian Groch - Chief Commercial Officer Jean-François Boily - VP, Finance David Waldman - President, Crescendo Communications Conference Call Participants Toby Ma - Mackie Research Chen Lin - Lin Asset Management Operator Good day, ladies and gentlemen, and welcome ...